Stock Market Reviews

AXSM (Axsome Therapeutics, Inc.) News

Get the latest news, insights, and market updates on AXSM (Axsome Therapeutics, Inc.). Explore the news page 6 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Market Movers: Nike Exploding Higher on Insider Buying
  Oversold shares of Nike (NYSE: NKE) are on the run. All on news that CEO Elliott Hill bought 16,400 shares for about $1 million. This follows news that Apple’s Tim Cook bought $3 million worth of Nike stock. Cook, who has been on the NKE board since 2005, bought 50,000 shares at an average price ... Market Movers: Nike Exploding Higher on Insider Buying
  Dec 31, 2025 - $AXSM
• Dow Jones Futures Rise; Palantir, GE Lead 12 Stocks In Buy Zones
  Bearish conditions on Wednesday turned bullish by Friday's close, with the S&P 500 and Nasdaq back above their 50-day lines. Palantir and GE lead a slew of new buys.
  Dec 22, 2025 - $AXSM
• Dow Jones Futures: Bulls In Charge; Palantir, GE Lead 12 Stocks In Buy Zones
  Bearish conditions on Wednesday turned bullish by Friday's close, with the S&P 500 and Nasdaq back above their 50-day lines. Palantir and GE lead a slew of new buys.
  Dec 20, 2025 - $AXSM
• Dow Jones Futures: Bearish To Bullish In Two Days; Palantir, GE Lead 12 Stocks In Buy Zones
  Bearish conditions on Wednesday turned bullish by Friday's close, with the S&P 500 and Nasdaq back above their 50-day lines. Palantir and GE lead a slew of new buys.
  Dec 20, 2025 - $AXSM
• Axsome (AXSM) Up 5.3% Since Last Earnings Report: Can It Continue?
  Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
  Dec 3, 2025 - $AXSM
• 2 Under-the-Radar Stocks to Buy Heading Into 2026
  These drugmakers are poised to profit from their innovative engines.
  Dec 2, 2025 - $AXSM
• Narcolepsy Market is Projected to Grow at a CAGR of 5.6% During the Forecast Period (2025-2034) Due to Increasing Disease Awareness, Improved Diagnosis, and Expanding Therapeutic Options | DelveInsight
  DelveInsight's Narcolepsy Market Insights report includes a comprehensive understanding of current treatment practices, narcolepsy emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into leading markets [the United States, the EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan].
  Dec 2, 2025 - $AXSM
• Axsome Therapeutics (AXSM): Evaluating Valuation Following Recent Share Price Momentum and Pipeline Expansion
  Axsome Therapeutics (AXSM) stock has shown some movement lately, catching the attention of investors curious about its momentum. Recent price action comes as the company continues to roll out its portfolio of central nervous system therapies and as it expands its pipeline. See our latest analysis for Axsome Therapeutics. Axsome’s recent 30-day share price return of 10.4% has helped push its year-to-date gain to an impressive 70.7%. This builds on a robust trend that has seen its 1-year total...
  Dec 2, 2025 - $AXSM
• Axsome (AXSM) Q3 2025 Earnings Call Transcript
  Herriot Tabuteau: Thank you, Darren, and good morning, everyone. AUVELITY continues to gain traction as a differentiated treatment for major depressive disorder, driven by strong underlying demand. SUNOSI remains on a steady trajectory with year-to-date sequential growth nearly double that of the same period last year, a testament to the product's durable performance and expanding adoption.
  Nov 27, 2025 - $AXSM
• Axsome Therapeutics to Participate in Upcoming Investor Conferences
  NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in the following upcoming investor conferences in December: Piper Sandler 37th Annual Healthcare Conference Fireside Chat: Wednesday, December 3, 2025, at 4:00 p.m. ET in New York, NY BofA Securities CNS Therapeutics Virtual Conference 2025 Fireside Chat: Monday, Dec
  Nov 20, 2025 - $AXSM